Scholarly Index

Masaomi Nangaku

The University of Tokyo; 35,843 total citations; 1,030 total publications; best world rank #5

The University of Tokyo

35,843Total citations
1,030Total publications
98H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Cancer, Hypoxia, and MetabolismLifetime75JP 299.68
Erythropoietin and Anemia TreatmentLifetime11JP 199.53
Renal Diseases and GlomerulopathiesLifetime49JP 199.55
Acute Kidney Injury ResearchLifetime28JP 199.45
Chronic Kidney Disease and DiabetesLifetime55JP 199.56
Dialysis and Renal Disease ManagementLifetime91JP 299.45
Complement system in diseasesLifetime59JP 498.98
Advanced Glycation End Products researchLifetime66JP 1198.71
Heme Oxygenase-1 and Carbon MonoxideLifetime81JP 898.43
High Altitude and HypoxiaLifetime67JP 198.60
Hemoglobinopathies and Related DisordersLifetime306JP 398.07
Diabetes Treatment and ManagementLifetime335JP 1298.71
Biomedical Research and PathophysiologyLifetime98JP 497.20
Blood transfusion and managementLifetime193JP 196.93
Eicosanoids and Hypertension PharmacologyLifetime490JP 2597.08
Renal and Vascular PathologiesLifetime549JP 796.88
Iron Metabolism and DisordersLifetime636JP 796.52
COVID-19 and healthcare impactsLifetime990JP 1691.83
Renin-Angiotensin System StudiesLifetime451JP 5596.00
Potassium and Related DisordersLifetime352JP 893.57
Gout, Hyperuricemia, Uric AcidLifetime617JP 5890.40
Neurological and metabolic disordersLifetime706JP 5389.55
Heterotopic Ossification and Related ConditionsLifetime818JP 10765.06
Nephrotoxicity and Medicinal PlantsLifetime977JP 7263.06
Dialysis and Renal Disease Management2021-202513JP 199.61
Erythropoietin and Anemia Treatment2021-20255JP 199.34
Blood transfusion and management2021-20257JP 198.65
Chronic Kidney Disease and Diabetes2021-202525JP 199.33
Diabetes Treatment and Management2021-202569JP 199.24
Cancer, Hypoxia, and Metabolism2021-202594JP 197.03
Hemoglobinopathies and Related Disorders2021-202575JP 197.31
Renal Diseases and Glomerulopathies2021-2025122JP 697.24
Hormonal Regulation and Hypertension2021-202582JP 496.33
Pancreatic function and diabetes2021-2025171JP 196.61
Iron Metabolism and Disorders2021-202598JP 295.57
COVID-19 and healthcare impacts2021-2025571JP 1692.29
Health Systems, Economic Evaluations, Quality of Life2021-2025897JP 693.39
Renal and Vascular Pathologies2021-2025219JP 690.44
Renal and related cancers2021-2025406JP 2189.35
Metabolism, Diabetes, and Cancer2021-2025466JP 2687.79
Advanced Glycation End Products research2021-2025144JP 785.86
Organ Donation and Transplantation2021-2025416JP 887.18
Mobile Health and mHealth Applications2021-2025820JP 584.55
Potassium and Related Disorders2021-2025178JP 1385.32
Parathyroid Disorders and Treatments2021-2025602JP 5284.89
Acute Kidney Injury Research2021-2025748JP 1178.62
Pharmacology and Obesity Treatment2021-2025341JP 677.86
Central Venous Catheters and Hemodialysis2021-2025852JP 3276.59
Biomedical Research and Pathophysiology2021-2025156JP 474.74
Biomedical Ethics and Regulation2021-2025378JP 1573.34
Healthcare cost, quality, practices2021-2025997JP 1568.47
Magnesium in Health and Disease2021-2025204JP 1967.78
Health Promotion and Cardiovascular Prevention2021-2025366JP 2765.59
Ion Transport and Channel Regulation2021-2025506JP 3162.34
Electrolyte and hormonal disorders2021-2025896JP 5460.75
Heterotopic Ossification and Related Conditions2021-2025169JP 1657.72
Eicosanoids and Hypertension Pharmacology2021-2025774JP 3458.09
Nitric Oxide and Endothelin Effects2021-2025815JP 2054.96
Alkaline Phosphatase Research Studies2021-2025149JP 1751.76
Cardiovascular, Neuropeptides, and Oxidative Stress Research2021-2025808JP 6332.40